Identification of Niemann-Pick C1 disease biomarkers through sphingolipid profiling
Niemann-Pick type C (NPC)1 is a rare neurodegenerative disease for which treatment options are limited. A major barrier to development of effective treatments has been the lack of validated biomarkers to monitor disease progression or serve as outcome measures in clinical trials. Using targeted meta...
Main Authors: | Martin Fan, Rohini Sidhu, Hideji Fujiwara, Brett Tortelli, Jessie Zhang, Cristin Davidson, Steven U. Walkley, Jessica H. Bagel, Charles Vite, Nicole M. Yanjanin, Forbes D. Porter, Jean E. Schaffer, Daniel S. Ory |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2013-10-01
|
Series: | Journal of Lipid Research |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0022227520353062 |
Similar Items
-
A sensitive and specific LC-MS/MS method for rapid diagnosis of Niemann-Pick C1 disease from human plasma[S]
by: Xuntian Jiang, et al.
Published: (2011-07-01) -
Sphingolipids in neurodegenerative diseases
by: Xueyang Pan, et al.
Published: (2023-02-01) -
ORMDL mislocalization by impaired autophagy in Niemann-Pick type C disease leads to increased de novo sphingolipid biosynthesis
by: Ryan D.R. Brown, et al.
Published: (2024-06-01) -
Exploring Sphingolipid Implications in Neurodegeneration
by: Alice V. Alessenko, et al.
Published: (2020-05-01) -
Sphingolipid biology /
by: Hirabayashi, Yoshio, et al.
Published: (2006)